DK2922571T3 - Farmaceutiske formuleringer, der omfatter carboran-holdige metallo-porphyriner - Google Patents
Farmaceutiske formuleringer, der omfatter carboran-holdige metallo-porphyrinerInfo
- Publication number
- DK2922571T3 DK2922571T3 DK13801495.6T DK13801495T DK2922571T3 DK 2922571 T3 DK2922571 T3 DK 2922571T3 DK 13801495 T DK13801495 T DK 13801495T DK 2922571 T3 DK2922571 T3 DK 2922571T3
- Authority
- DK
- Denmark
- Prior art keywords
- carboran
- porphyrines
- metallo
- pharmaceutical formula
- formula containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
- A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1221125.6A GB201221125D0 (en) | 2012-11-23 | 2012-11-23 | Pharmaceutial formulations |
| PCT/EP2013/074490 WO2014079977A1 (en) | 2012-11-23 | 2013-11-22 | Pharmaceutical formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2922571T3 true DK2922571T3 (da) | 2017-11-13 |
Family
ID=47560584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13801495.6T DK2922571T3 (da) | 2012-11-23 | 2013-11-22 | Farmaceutiske formuleringer, der omfatter carboran-holdige metallo-porphyriner |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9358290B2 (da) |
| EP (1) | EP2922571B1 (da) |
| JP (1) | JP6279599B2 (da) |
| KR (1) | KR20150086283A (da) |
| CN (1) | CN104853777B (da) |
| CA (1) | CA2890271A1 (da) |
| CY (1) | CY1119713T1 (da) |
| DK (1) | DK2922571T3 (da) |
| ES (1) | ES2646010T3 (da) |
| GB (1) | GB201221125D0 (da) |
| HK (1) | HK1209339A1 (da) |
| HR (1) | HRP20171652T1 (da) |
| HU (1) | HUE035198T2 (da) |
| LT (1) | LT2922571T (da) |
| NO (1) | NO2922571T3 (da) |
| PL (1) | PL2922571T3 (da) |
| PT (1) | PT2922571T (da) |
| RS (1) | RS56499B1 (da) |
| SI (1) | SI2922571T1 (da) |
| WO (1) | WO2014079977A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201212409D0 (en) * | 2012-07-12 | 2012-08-22 | Morex Dev Partners Llp | Cancer treatment |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4925736A (en) | 1988-07-06 | 1990-05-15 | Long Island Jewish Medical Center | Topical hematoporphyrin |
| CA2466425A1 (en) | 2001-11-09 | 2003-05-15 | Qlt Inc. | Photodynamic therapy for the treatment of hair loss |
| US6995260B2 (en) * | 2004-05-20 | 2006-02-07 | Brookhaven Science Associates, Llc | Carboranylporphyrins and uses thereof |
| US8287839B2 (en) * | 2006-12-04 | 2012-10-16 | Brookhaven Science Associates, Llc | Carboranylporphyrins and uses thereof |
| US8444953B2 (en) * | 2007-03-22 | 2013-05-21 | Brookhaven Science Associates, Llc | Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof |
| WO2009031489A1 (ja) * | 2007-09-03 | 2009-03-12 | Kawamura Institute Of Chemical Research | ナノ構造複合体被覆型構造物の製造方法、ナノ構造複合体被覆型構造物及びこれを用いるリアクター |
| GB0819594D0 (en) | 2008-10-24 | 2008-12-03 | Univ Coimbrra | Process |
| GB201212409D0 (en) * | 2012-07-12 | 2012-08-22 | Morex Dev Partners Llp | Cancer treatment |
-
2012
- 2012-11-23 GB GBGB1221125.6A patent/GB201221125D0/en not_active Ceased
-
2013
- 2013-11-22 ES ES13801495.6T patent/ES2646010T3/es active Active
- 2013-11-22 US US14/646,527 patent/US9358290B2/en active Active
- 2013-11-22 NO NO13801495A patent/NO2922571T3/no unknown
- 2013-11-22 SI SI201330816T patent/SI2922571T1/sl unknown
- 2013-11-22 CN CN201380060998.8A patent/CN104853777B/zh not_active Expired - Fee Related
- 2013-11-22 DK DK13801495.6T patent/DK2922571T3/da active
- 2013-11-22 JP JP2015543441A patent/JP6279599B2/ja not_active Expired - Fee Related
- 2013-11-22 EP EP13801495.6A patent/EP2922571B1/en active Active
- 2013-11-22 KR KR1020157013960A patent/KR20150086283A/ko not_active Application Discontinuation
- 2013-11-22 WO PCT/EP2013/074490 patent/WO2014079977A1/en active Application Filing
- 2013-11-22 PL PL13801495T patent/PL2922571T3/pl unknown
- 2013-11-22 PT PT138014956T patent/PT2922571T/pt unknown
- 2013-11-22 LT LTEP13801495.6T patent/LT2922571T/lt unknown
- 2013-11-22 RS RS20171110A patent/RS56499B1/sr unknown
- 2013-11-22 HU HUE13801495A patent/HUE035198T2/hu unknown
- 2013-11-22 CA CA2890271A patent/CA2890271A1/en not_active Abandoned
-
2015
- 2015-10-15 HK HK15110095.6A patent/HK1209339A1/xx not_active IP Right Cessation
-
2017
- 2017-10-30 HR HRP20171652TT patent/HRP20171652T1/hr unknown
- 2017-10-31 CY CY20171101132T patent/CY1119713T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104853777A (zh) | 2015-08-19 |
| CY1119713T1 (el) | 2018-06-27 |
| EP2922571A1 (en) | 2015-09-30 |
| SI2922571T1 (sl) | 2017-12-29 |
| WO2014079977A1 (en) | 2014-05-30 |
| CN104853777B (zh) | 2019-03-08 |
| US9358290B2 (en) | 2016-06-07 |
| ES2646010T3 (es) | 2017-12-11 |
| LT2922571T (lt) | 2017-11-10 |
| HRP20171652T1 (hr) | 2017-12-15 |
| NO2922571T3 (da) | 2018-02-03 |
| RS56499B1 (sr) | 2018-01-31 |
| HK1209339A1 (en) | 2016-04-01 |
| JP6279599B2 (ja) | 2018-02-14 |
| PL2922571T3 (pl) | 2018-03-30 |
| JP2016500090A (ja) | 2016-01-07 |
| KR20150086283A (ko) | 2015-07-27 |
| EP2922571B1 (en) | 2017-09-06 |
| PT2922571T (pt) | 2017-11-07 |
| HUE035198T2 (hu) | 2018-05-02 |
| US20150297717A1 (en) | 2015-10-22 |
| GB201221125D0 (en) | 2013-01-09 |
| CA2890271A1 (en) | 2014-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO7010838A2 (es) | Compuestos de imidazopirrolidinona | |
| DK3536310T3 (da) | Sprøjte | |
| DK3381444T3 (da) | Sprøjte | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| CO6990736A2 (es) | Pirrolidina-2-carboxamidas sustituídas | |
| DK2939692T3 (da) | Nasal influenzavaccinesammensætning | |
| DK3043778T3 (da) | Farmaceutiske sammensætninger, der indeholder refametinib | |
| UA24760S (uk) | Шрифт | |
| DK2900645T3 (da) | Herbicidt aktive 3-phenylisoxazolinderivater | |
| CO7020919A2 (es) | Derivados de tetrahidro-quinazolinona | |
| DK2897594T3 (da) | Farmaceutisk sammensætning | |
| CL2014003283A1 (es) | Formulación farmacéutica. | |
| DK2804611T3 (da) | Chitosanafledte forbindelser | |
| BR112014009319A2 (pt) | compostos farmacêuticos | |
| DK2854765T3 (da) | Farmaceutisk pemetrexed-opløsning | |
| CO7091176A2 (es) | Diagnóstico farmacéutico | |
| DK2851075T3 (da) | Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat | |
| SMT201600419B (it) | Composizione farmaceutica contenente fosfolipidi | |
| DE102013212400A8 (de) | Abdeckplattenstützbaugruppe | |
| DK2922571T3 (da) | Farmaceutiske formuleringer, der omfatter carboran-holdige metallo-porphyriner | |
| BR112014021433A2 (pt) | formulações farmacêuticas | |
| BR302012003979S1 (pt) | Configuração aplicada em fármaco | |
| DE102012112916A8 (de) | Dosiermodul | |
| DK2822938T3 (da) | Rodenticide norbormidanaloger | |
| FR2997638B1 (fr) | Cristallisoir |